LEADER 02400nam  2200337 n 450 
001 9910674381403321
005 20230623153452.0
035   $a(CKB)3800000000216554
035   $a(NjHacI)993800000000216554
035   $a(EXLCZ)993800000000216554
100   $a20230623d2017      uy             0
101 0 $aeng
135   $aur|||||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aCurrent Knowledge in Thyroid Cancer - From Bench to Bedside /$fDaniela Gabriele Grimm, editor
210  1$aBasel :$cMDPI AG - Multidisciplinary Digital Publishing Institute,$d2017.
215   $a1 online resource (220 pages) $cillustrations
311   $a3-03842-476-5 
330   $aAnnotation In recent years, studies in the field of thyroid cancer have been performed in order to identify and verify thyroid specific biomarkers, as well as cancer-specific changes in gene expression patterns and alterations of the protein content. Furthermore, new drugs, small molecules and antibodies were developed and tested in vitro and in vivo. Trials investigated the ratio between therapeutic and adverse effects. Tyrosine kinase inhibitors (TKI) have become a new therapeutic option of both differentiated thyroid cancer and medullary thyroid cancer. In the last few years, new substances for targeted systemic therapy have been approved after their efficacy was demonstrated in Phase III trials. Most of them show a moderate response. However, adverse effects are common. TKI are used in patients with advanced metastatic thyroid cancer that is radioiodine (RAI)-refractory. In this Special Issue, original studies on the pathophysiology, diagnosis, and therapy of thyroid cancer, including genetics, proteomics, metabolomics, molecular and cell biology, will be published. It will also cover reports on patients, providing novel mechanistic insights into the underlying pathogenesis or new aspects that may impact clinical therapy, and recent study results in order to review the current status of new therapy options in thyroid cancer.
606   $aThyroid hormones
615  0$aThyroid hormones.
676   $a612.44
702   $aGrimm$b Daniela Gabriele
801  0$bNjHacI
801  1$bNjHacl
906   $aBOOK
912   $a9910674381403321
996   $aCurrent Knowledge in Thyroid Cancer ? From Bench to Bedside$92990441
997   $aUNINA